Net Loss of Vivanza Biosciences reported to Rs 0.41 crore in the quarter ended March 2024 as against net loss of Rs 0.10 crore during the previous quarter ended March 2023. Sales declined 46.36% to Rs 4.42 crore in the quarter ended March 2024 as against Rs 8.24 crore during the previous quarter ended March 2023.For the full year,net profit declined 8.33% to Rs 0.55 crore in the year ended March 2024 as against Rs 0.60 crore during the previous year ended March 2023. Sales rose 56.32% to Rs 27.84 crore in the year ended March 2024 as against Rs 17.81 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales4.428.24 -46 27.8417.81 56 OPM %-2.940 -3.843.71 - PBDT-0.260.02 PL 0.710.72 -1 PBT-0.270.01 PL 0.700.72 -3 NP-0.41-0.10 -310 0.550.60 -8 Powered by Capital Market - Live News

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 30 April 2024.Powered by Capital Market - Live News

Net profit of Vivanza Biosciences declined 54.35% to Rs 0.21 crore in the quarter ended December 2023 as against Rs 0.46 crore during the previous quarter ended December 2022. Sales rose 11.95% to Rs 6.56 crore in the quarter ended December 2023 as against Rs 5.86 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales6.565.86 12 OPM %4.429.56 - PBDT0.210.46 -54 PBT0.210.46 -54 NP0.210.46 -54 Powered by Capital Market - Live News

Vivanza Biosciences will hold a meeting of the Board of Directors of the Company on 6 February 2024. The meeting would commence at 3.30 pm.Powered by Capital Market - Live News

Net profit of Vivanza Biosciences rose 52.94% to Rs 0.26 crore in the quarter ended September 2023 as against Rs 0.17 crore during the previous quarter ended September 2022. Sales rose 464.44% to Rs 7.62 crore in the quarter ended September 2023 as against Rs 1.35 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales7.621.35 464 OPM %4.20-2.22 - PBDT0.260.16 63 PBT0.260.16 63 NP0.260.17 53 Powered by Capital Market - Live News